How hospice became big business. A new investigation in The New Yorker reveals an industry that at times puts profits before patients.
Sixty distinguished scientists last month criticized the Bush administration for how it uses scientific information in making policy, how it handles the selection of scientists for federal advisory panels, and other scientific issues. The current and former director of the federal Office of Science and Technology Policy join Diane to talk about this statement and the questions it raises.
- Dr. John Marburger Director, Office of Science and Technology Policy
- Dr. Neal Lane Former Presidential Science advisor and former director of the National Science Foundation
Most Recent Shows
Pulitzer Prize-winning biographer Jon Meacham on the evolution of Abraham Lincoln's moral principles and political leadership -- and what the era of Lincoln can teach us about the state of our democracy today.
What troubles at Twitter say about the state of social media -- and why one tech watcher argues this could transform the industry in positive ways.
Political analyst Norman Ornstein on control of Congress, the red wave that wasn't, and other lessons from the midterm elections.